Robert J. Lutz
e-Therapeutics (United Kingdom)(GB)
Publications by Year
Research Areas
HER2/EGFR in Cancer Research, Monoclonal and Polyclonal Antibodies Research, Risk and Safety Analysis, CAR-T cell therapy research, Peptidase Inhibition and Analysis
Most-Cited Works
- → Targeting HER2-Positive Breast Cancer with Trastuzumab-DM1, an Antibody–Cytotoxic Drug Conjugate(2008)1,659 cited
- → Bax interacts with the permeability transition pore to induce permeability transition and cytochromecrelease in isolated mitochondria(1998)923 cited
- → Induction of apoptosis by the Bcl-2 homologue Bak(1995)734 cited
- → Antibody-Maytansinoid Conjugates Are Activated in Targeted Cancer Cells by Lysosomal Degradation and Linker-Dependent Intracellular Processing(2006)569 cited
- → A conserved domain in Bak, distinct from BH1 and BH2, mediates cell death and protein binding functions.(1995)490 cited
- → Expression of bbc3 , a pro-apoptotic BH3-only gene, is regulated by diverse cell death and survival signals(2001)420 cited